Engage Therapeutics

Dedicated to helping the #epilepsy community #stopseizures and live healthier lives.

[Engage Therapeutics @EngageEpilepsy]

Today, Engage Therapeutics Announces Phase 2b StATES Study of Staccato® Alprazolam for #Seizure Cessation Meets #PrimaryEndpoint
--- #Staccatoalprazolam achieved a statistically significant response rate. Avgerage time to seizure cessation was 30 secs https://t.co/NdkcqzbzTI

[Engage Therapeutics @EngageEpilepsy]

"#Staccatoalprazolam has demonstrated the ability to rapidly terminate seizures in patients with epilepsy in two minutes or less and prevent recurrence of seizure within two hours.” Read more by visiting our #news section on https://t.co/DT5BMWrbPJ to read the latest!

[NeurologyLive® @neurology_live]

"The intent is to go to the FDA with an indication for people who need rapid control of seizure activity."

A Q&A with Jacqueline French of @nyulangone discusses recent findings of alprazolam 🧠:
https://t.co/0ySm8Vnm2K

[Engage Therapeutics @EngageEpilepsy]

Check out this important interview with our Principal Investigator, Dr. Jacqueline French, MD discussing the recent study findings from our Phase 2b trial of Staccato Alprazolam. #epilepsy #clinicalresearch #clinicaltrials

https://t.co/PLW9rW50EC

[NeurologyLive® @neurology_live]

The president and CEO of @EngageEpilepsy, along with the company’s executive VP and COO, discussed its investigational Staccato alprazolam product in the abortive treatment of #seizures.

https://t.co/HAhDhfmLPt

[Danny Did Foundation @DannyDidOrg]

For #PurpleDay for Epilepsy Awareness, we ask friends to donate $26 for the #1in26 Americans facing #epilepsy. We know many people & businesses are hurting, & we empathize. A RT also helps. We are #grateful, we are resilient & we are here! https://t.co/srAAx6ytlV
#virtualsupport

[LSI - Life Science Intelligence™ @lsintelligence]

Another #innovator in #medtech charging ahead and making a difference in patients' lives and #healthcare. Congrats @EngageEpilepsy on your progress, we look forward to seeing you grow.

More on this innovator: https://t.co/lHvIRkDIZl

[Engage Therapeutics @EngageEpilepsy]

We are honored to be selected as an #innovation Leader at LSI’s Emerging #Medtech Summit 2020. Check out this article on our easy-to-use, hand-held drug-device combination product for use in the cessation of active and acute #epileptic #seizures.

https://t.co/7dc1imt8VX

[NeurologyLive® @neurology_live]

ICYMI: @EngageEpilepsy has announced that its investigational abortive #seizure treatment Staccato #alprazolam has met its primary end point in the phase 2 StATES study.

https://t.co/VKX2yXAWzP

[NeurologyLive® @neurology_live]

.@EngageEpilepsy has announced that its investigational abortive #seizure treatment Staccato #alprazolam has met its primary end point in the phase 2 StATES study.

https://t.co/VKX2yXAWzP

[Engage Therapeutics @EngageEpilepsy]

“We are now one step closer to bringing to patients an EpiPen® like rescue treatment that works fast enough to terminate an active seizure episode.” https://t.co/ZDzWfaUk01

[AngelWingsFoundation @AngelWingsFdn]

Wonderful news for those living with #epilepsy.

[Kurt Eichenwald @kurteichenwald]

For those with epilepsy: Im thrilled. An orally inhalable med by @EngageEpilepsy that can stop a seizure has finished stage 2 clinical trials. Results: Success in stopping for a statistically significant number of test subjects. On to outpatient tests. https://t.co/9DPmXFlGFh

[STAT @statnews]

It’s a particularly poignant win for Engage, which was founded by the father of a child with uncontrolled epilepsy in hopes that the company’s treatments will help tame his and other children’s seizures. https://t.co/hPvhDr1J7L

[Luke Whitmire @WhitmirePhD]

https://t.co/DfVHjVbBqc

[Danny Did Foundation @DannyDidOrg]

Key progress in clinical trials for a promising new emergency med for people with #epilepsy

[Michelle Theeuwes @mnmtheeuwes]

@TalkAboutItorg I think this is some good news to talk about!!

[Lumira Ventures @LumiraVentures]

#Staccatoalpazolam has demonstrated the ability to rapidly terminate #seizures in #patients with #epilepsy in 2 min or less & prevent recurrence of seizures within 2 hrs. Read more about @EngageEpilepsy's #clinicalstudy findings here: https://t.co/q2kmkEbs4g #biotech #investor

[Engage Therapeutics @EngageEpilepsy]

The @EngageEpilepsy team is hard at work raising awareness about #epilepsy through epilepsy walks, local charity events, and #biotech conferences! #EpilepsyDay is every day for us! #endepilepsy #InternationalEpilepsyDay

[Engage Therapeutics @EngageEpilepsy]

The @EngageEpilepsy team celebrates #EpilepsyDay everyday! #engagetherapeutics